FENNEC PHARMACEUTICALS INC. (FENC)

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Address

PO BOX 13628
RESEARCH TRIANGLE PARK, NC 27709

Founded

1996

Number of Employees

29

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)